Cargando…

Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists

Dendritic cell (DC) vaccines have been demonstrated to elicit immunological responses in numerous cancer immunotherapy trials. However, long-lasting clinical effects are infrequent. We therefore sought to establish a protocol to generate DC with greater immunostimulatory capacity. Immature DC were g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lövgren, Tanja, Sarhan, Dhifaf, Truxová, Iva, Choudhary, Bhavesh, Maas, Roeltje, Melief, Jeroen, Nyström, Maria, Edbäck, Ulrika, Vermeij, Renee, Scurti, Gina, Nishimura, Michael, Masucci, Giuseppe, Karlsson-Parra, Alex, Lundqvist, Andreas, Adamson, Lars, Kiessling, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626805/ https://www.ncbi.nlm.nih.gov/pubmed/28601925 http://dx.doi.org/10.1007/s00262-017-2029-4

Ejemplares similares

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination
por: Lövgren, Tanja, et al.
Publicado: (2020)

Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity
por: Mao, Yumeng, et al.
Publicado: (2014)

Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
por: de Coaña, Yago Pico, et al.
Publicado: (2017)

High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma
por: Melief, Jeroen, et al.
Publicado: (2020)

Regulation of TRAIL-Receptor Expression by the Ubiquitin-Proteasome System
por: Sarhan, Dhifaf, et al.
Publicado: (2014)

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells
por: Kiessling, Rolf, et al.
Publicado: (2012)

Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display
por: Wickström, Stina L., et al.
Publicado: (2019)

Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours
por: Masucci, Giuseppe V, et al.
Publicado: (2012)

HLA-dependent tumour development: a role for tumour associate macrophages?
por: Marchesi, Maddalena, et al.
Publicado: (2013)

Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
por: Truxova, Iva, et al.
Publicado: (2023)

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
por: Andersson, Emilia, et al.
Publicado: (2015)

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
por: Dahlberg, Carin I. M., et al.
Publicado: (2015)

Genetic Modification of T Cells for the Immunotherapy of Cancer
por: Quinn, Suzanne, et al.
Publicado: (2022)

Melanoma reactive TCR-modified T cells generated without activation retain a less differentiated phenotype and mediate a superior in vivo response
por: Wang, Siao-Yi, et al.
Publicado: (2021)

Self-Delivering RNAi Targeting PD-1 Improves Tumor-Specific T Cell Functionality for Adoptive Cell Therapy of Malignant Melanoma
por: Ligtenberg, Maarten A., et al.
Publicado: (2018)

Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid derived suppressor cells as well as their arginase1 production
por: Gentilcore, Giusy, et al.
Publicado: (2014)

Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients
por: Pico de Coaña, Yago, et al.
Publicado: (2014)

Family talk intervention in paediatric oncology: a pilot study protocol
por: Lövgren, Malin, et al.
Publicado: (2019)

PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates
por: Pico de Coaña, Yago, et al.
Publicado: (2020)

Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma
por: Laurell, Anna, et al.
Publicado: (2017)

Upregulation of Toll-like receptor 2 and nuclear factor-kappa B expression in experimental colonic schistosomiasis
por: Ashour, Dalia S., et al.
Publicado: (2015)

Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies
por: Vermeij, R., et al.
Publicado: (2011)

Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
por: Regan, Courtney, et al.
Publicado: (2013)

The family talk intervention in palliative care: a study protocol
por: Eklund, Rakel, et al.
Publicado: (2018)

Improved Expression of Recombinant Human Factor IX by Co-expression of GGCX, VKOR and Furin
por: Liu, Jianming, et al.
Publicado: (2014)

Using Communication Tools to Explore Young Siblings’ Experiences of Having a Brother or Sister with Pediatric Palliative Care Needs
por: Kreicbergs, Ulrika, et al.
Publicado: (2022)

Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25(+)/CD54(+) NK cells
por: Chen, Ziqing, et al.
Publicado: (2021)

Physicians working in oncology identified challenges and factors that facilitated communication with families when children could not be cured
por: Udo, Camilla, et al.
Publicado: (2019)

The family talk intervention for families when a parent is cared for in palliative care – potential effects from minor children’s perspectives
por: Eklund, Rakel, et al.
Publicado: (2020)

“Suddenly we have hope that there is a future”: two families’ narratives when a child with spinal muscular atrophy receives a new drug
por: Hjorth, Elin, et al.
Publicado: (2021)

Communication about diagnosis and prognosis—A population‐based survey among bereaved parents in pediatric oncology
por: Bartholdson, Cecilia, et al.
Publicado: (2022)

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer
por: Pavlenko, M, et al.
Publicado: (2004)

Non-classical HLA-E restricted CMV 15-mer peptides are recognized by adaptive NK cells and induce memory responses
por: Martín Almazán, Nerea, et al.
Publicado: (2023)

Counteracting CAR T cell dysfunction
por: Poorebrahim, Mansour, et al.
Publicado: (2021)

FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation
por: Gultekin, Okan, et al.
Publicado: (2021)

Enzymatic Functions for Toll/Interleukin-1 Receptor Domain Proteins in the Plant Immune System
por: Bayless, Adam M., et al.
Publicado: (2020)

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy
por: MIKYŠKOVÁ, ROMANA, et al.
Publicado: (2015)

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
por: Partlová, Simona, et al.
Publicado: (2015)

Independent control of natural killer cell responsiveness and homeostasis at steady-state by CD11c+ dendritic cells
por: Luu, Thuy Thanh, et al.
Publicado: (2016)

Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control
por: Kesarwani, Pravin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uv6sqvlpbdh9lg40u34jh9hnqg